Jul 02

M.M DILLON & CO SERVES AS FINANCIAL ADVISOR TO CAREDX INC IN ITS ACQUISITION OF ALLENEX AB

MM Dillon acted as an advisor to CareDx, Inc. (Nasdaq:CDNA) the completion of its previously announced acquisition of publically traded Allenex AB. The acquisition included a successful tender of 98.37% of Allenex shares as part of a public tender offer concluded in Sweden. CareDx will be able to buy out the remaining shares on a compulsory basis because more than 90% of Allenex shares were tendered. The combination of CareDx and Allenex created an international transplant diagnostics company with product offerings focused on transplantation. Allenex based in Sweden has approximately 58 employees.

About CareDx, Inc

CareDx, Inc., based in Brisbane, California, is a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value diagnostic surveillance solutions for transplant patients. The company has commercialized AlloMap®, a gene expression test that aids clinicians in identifying heart transplant patients with stable graft function who have a low probability of moderate/severe acute cellular rejection. CareDx is also pursuing the development of additional products for transplant monitoring using a variety of technologies, including AlloSureTM, its next-generation sequencing–based test to detect donor-derived cell-free DNA after transplantation. For more information, please visit: www.CareDx.com.

About M.M. Dillon & Co.

M.M. Dillon & Co. (formerly CRT Investment Banking LLC) is an employee owned partnership where industry and product specialists collaborate closely to provide creative, idea-driven advice and solutions to its institutional and corporate clients. M.M. Dillon offers public and private financing, M&A advisory and restructuring advisory services. M.M. Dillon’s team of experienced professionals provides execution capabilities for companies across a range of industry sectors. The firm’s senior banking professionals have a minimum of 20 years of experience with major Wall Street firms.

Leave a reply

Your email address will not be published. Required fields are marked *